Product Name | HLYVSPWGGGGWLTRLLQTK |
Product Quantity | 4mg |
Catalog Number | 6276 |
Category | Peptide |
Sequence | HLYVSPWGGGGWLTRLLQTK, His-Leu-Tyr-Val-Ser-Pro-Trp-Gly-Gly-Gly-Gly-Trp-Leu-Thr-Arg-Leu-Leu-Gln-Thr-Lys (H-L-Y-V-S-P-W-G-G-G-G-W-L-T-R-L-L-Q-T-K) |
Purity | >95% |
Modifications | The chimeric peptide has a cell-penetrating peptide sequence and a fusion peptide sequence. The polypeptide can form the alpha helix. The polypeptide specifically binds to TRB3 (Tribbeles Homologue 3). The peptide could be used for treating and preventing pulmonary fibrosis. The synthetic peptide has the advantages of obvious curative effect, less toxic and side effects and safe use in treating pulmonary fibrosis diseases. |
Scientific Background | HLYVSPWGGGGWLTRLLQTK is a 20-residue synthetic peptide with the sequence His-Leu-Tyr-Val-Ser-Pro-Trp-Gly-Gly-Gly-Gly-Trp-Leu-Thr-Arg-Leu-Leu-Gln-Thr-Lys. The sequence contains 3 aromatic residues that can contribute to hydrophobic or aromatic interactions. These sequence-derived properties describe the reagent chemically; no specific receptor, enzyme, pathway, disease association, or biological activity is assigned without product-specific experimental evidence. |
Research Applications | - LC-MS/HPLC analytical method development
- sequence-specific assay controls
|
Experimental Notes | Sequence-derived chemical properties support reagent selection and experimental planning but do not establish biological function. Solubility, aggregation, adsorption, conjugation efficiency, and assay performance should be validated under the intended experimental conditions. |
